David A. Siegel Treace Medical Concepts, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 32,200 shares of TMCI stock, worth $185,794. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,200
Previous 47,900
32.78%
Holding current value
$185,794
Previous $356,000
24.16%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TMCI
# of Institutions
142Shares Held
39MCall Options Held
39.7KPut Options Held
3K-
Armistice Capital, LLC New York, NY6.21MShares$35.8 Million0.79% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$23.5 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.06MShares$17.7 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$15.6 Million0.0% of portfolio
-
Cibc Private Wealth Group, LLC2.29MShares$13.2 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $320M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...